Academic Malignant Hematologists

Academic Malignant Hematologists, Division of Medical Oncology and Hematology

Princess Margaret Cancer Centre, University Health Network

Assistant / Associate / Full Professor)

Clinician Scientist, Investigator, Teacher, Quality & Innovation

The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit energetic and innovative physicians with expertise in malignant hematology, with a keen focus in Myeloma / Lymphoma.

Each successful applicant will have an academic position description of either Clinician Teacher, Quality & Innovation, Scientist or Investigator.

Each successful applicant must be eligible for a Full Time Clinical Academic appointment at the rank of Assistant Professor or higher.

The anticipated start date is November 1, 2024 , or shortly thereafter.

Each successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in research, teaching and / or quality improvement.

The successful applicant will join a multidisciplinary team in the management of patients with hematological malignancies within a comprehensive cancer centre setting and, will be expected to engage in clinical, translational, or basic research.

Other responsibilities include teaching at the undergraduate and postgraduate levels.

The Malignant Hematology Program within the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre is the largest such program in Canada, and is among the largest in North America.

Comprised of about thirty senior physicians, the Malignant Hematology Program is supported by outstanding institutional infrastructure including hematopathology, cytogenetics and molecular diagnostics programs led by a wide medical and allied health multidisciplinary team.

The program supports extensive clinical, translational, and basic research initiatives including a large clinical trials program.

Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.

Ranked in the top 10 on Newsweek’s list of the World’s Best Specialized Hospitals 2023, the Princess Margaret Cancer Centre continues to be on the frontiers of medical, surgical and radiation oncology, embracing the latest technology and international best-practices and setting standards for patient care.

The Princess Margaret Cancer Centre includes the Princess Margaret Research Institute (formerly the Ontario Cancer Institute - OCI).

This is a world-class basic and translational research institute with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics.

The close association between clinicians and scientists provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine.

In addition, the Princess Margaret Cancer Centre supports active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility.

Princess Margaret Cancer Centre is affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others.

Princess Margaret Cancer Centre is also a teaching hospital, dedicated to educating the world’s future top cancer experts.

Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology

It is expected that the candidate will be hired into one of the University of Toronto Clinician Investigator, Clinician Teacher, or Clinician Quality & Innovation tracks.

For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards.

For Clinician Scientists and Investigators, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments.

Each successful applicant must also hold a MD degree as well as specialist designation in Clinical Hematology or Medical Oncology, or equivalent.

Each successful applicant must also have, or be eligible for both registration with the College of Physicians and Surgeons of Ontario and FRCPC qualifications.

Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate.

A highly attractive remuneration package is available.

Should you be interested in this exciting opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three (3) referees to :

Dr. Amit Oza - Chief, Division of Medical Oncology and Hematology

c / o Michelle Williams, Business Manager

Princess Margaret Cancer Centre, University Health Network

Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5

Office : 416.946.2341

Fax : 416.946.2082 E-mail :

Applications will be accepted until all positions are filled.

For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit :

For more information on Sinai Health and our world-renowned programs, visit :

For more information about the Department of Medicine at the University of Toronto, please visit our website at .

All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.

Diversity Statement

The University of Toronto, University Health Network and Sinai Health System are strongly committed to diversity within its community and especially welcomes applications from racialized persons / persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ2S+ persons, and others who may contribute to the further diversification of ideas.

Accessibility Statement

The University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members.

Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission.

The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment, assessment and selection processes as accessible as possible and prove accommodations as required for applicants with disabilities.